These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23026650)

  • 21. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
    Roberts MA; Hare DL; Ratnaike S; Ierino FL
    Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do novel biomarkers add to existing scores of total cardiovascular risk?
    De Backer G; Graham I; Cooney MT
    Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):14-7. PubMed ID: 22801065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of inflammatory markers and endothelial function.
    Järvisalo MJ; Juonala M; Raitakari OT
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):547-52. PubMed ID: 16912549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar.
    Welsh P; Packard CJ; Sattar N
    Curr Opin Lipidol; 2008 Dec; 19(6):563-71. PubMed ID: 18957878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction.
    Münzel T; Sinning C; Post F; Warnholtz A; Schulz E
    Ann Med; 2008; 40(3):180-96. PubMed ID: 18382884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of weight loss from a high-calcium energy-reduced diet on biomarkers of inflammatory stress, fibrinolysis, and endothelial function in obese subjects.
    Torres MR; Sanjuliani AF
    Nutrition; 2013 Jan; 29(1):143-51. PubMed ID: 23010419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inflammatory markers and cytokines in cardiovascular disease].
    Ogiwara F; Takahashi M; Ikeda U
    Rinsho Byori; 2004 Aug; 52(8):686-92. PubMed ID: 15478624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers for cardiovascular risk in children.
    Canas JA; Sweeten S; Balagopal PB
    Curr Opin Cardiol; 2013 Mar; 28(2):103-14. PubMed ID: 23337894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of the new cardiovascular risk markers in diabetes mellitus.
    Iglesias P; Pedro-Botet J; Arrieta F; Aguilar M; Escobar On Behalf Of The Working Group On Diabetes And Cardiovascular Disease Of The Spanish Society Of Diabetes F
    Curr Diabetes Rev; 2015; 11(4):273-80. PubMed ID: 25808417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein-associated phospholipase A(2): a promising vascular-specific marker for screening cardiovascular risk?
    Lee JH; Engler MM
    Prog Cardiovasc Nurs; 2009 Dec; 24(4):181-9. PubMed ID: 20002343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular biomarkers in chronic kidney disease.
    Park SH; Stenvinkel P; Lindholm B
    J Ren Nutr; 2012 Jan; 22(1):120-7. PubMed ID: 22200428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple biomarkers for the prediction of first major cardiovascular events and death.
    Wang TJ; Gona P; Larson MG; Tofler GH; Levy D; Newton-Cheh C; Jacques PF; Rifai N; Selhub J; Robins SJ; Benjamin EJ; D'Agostino RB; Vasan RS
    N Engl J Med; 2006 Dec; 355(25):2631-9. PubMed ID: 17182988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory biomarkers for predicting cardiovascular disease.
    Stoner L; Lucero AA; Palmer BR; Jones LM; Young JM; Faulkner J
    Clin Biochem; 2013 Oct; 46(15):1353-71. PubMed ID: 23756129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should we focus on novel risk markers and screening tests to better predict and prevent cardiovascular disease? Point.
    Enriquez JR; de Lemos JA
    Prev Cardiol; 2010; 13(4):152-9. PubMed ID: 20860637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.
    Sen S; McDonald SP; Coates PT; Bonder CS
    Clin Sci (Lond); 2011 Apr; 120(7):263-83. PubMed ID: 21143202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers for the prediction of mortality and morbidity in patients with renal replacement therapy.
    Chaykovska L; Tsuprykov O; Hocher B
    Clin Lab; 2011; 57(7-8):455-67. PubMed ID: 21888009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.